Amyloid Cardiomyopathy

Association Between Lifetime Physical Activity and Exercise and the Development of Wild-type Transthyretin Amyloid Cardiomyopathy

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

Monitoring of Early Disease Progression in Hereditary Transthyretin Amyloidosis

Myocardial Perfusion CMR for Differentiating and Characterizing Hypertrophic Cardiomyopathy Phenotypes

Amyloidosis TTR Flow Reserve Evaluation

Enavogliflozin for the Management of Patients With Amyloid CardiomyopaThy

To Evaluate the Long-term Safety and Tolerability of Acoramidis in Participants With Newly Diagnosed ATTR-CM (ACT-EARLY OLE)

Genistein in trAnSthyretin recePtor Amyloid caRdiomyopathy

Swiss Cardiac Amyloidosis REgistry (Swiss-CARE)

Exercise Training in Transthyretin Cardiac Amyloidosis

Open-Label Study of AG10 in Patients with Cardiomyopathy

Administration of the SGLT-2 Inhibitor Dapagliflozin in the Patients With Amyloid Cardiomyopathy

AI-enabled Screening and Diagnosis of Cardiomyopathies Using Coronary CTA

EOSS-ATTR Study (eHealth Based Operative Support System in ATTR-CM)

Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Cardiomyopathy

Artificial Intelligence to Assist the Echocardiographic Identification of Transthyretin Cardiac Amyloidosis

Longitudinal Changes in Left and Right Ventricular Global Strain After Chemotherapy in Cardiac Light Chain Amyloidosis

Left Atrial Strain and Supraventricular Arrhythmia Burden in Cardiac Light Chain Amyloidosis Following Chemotherapy

18F-florbetaben PET-CT to Non-invasively Diagnose Cardiac AL Amyloidosis

Screening of ATTRwt in Patient With Advanced AV-Block Undergoing Pacemaker Implantation